1. Everitt, E. and Wohlfart, C., Spectrophotometric quantitation of anchorage-dependent cell numbers extraction of naphthol blue-black-stained cellular protein.Anal. Biochem., 162(1), 122–9 (1987).
2. Hainsworth, J. D., Handle, K. R., Satterlee, W. G., Kuttesch, J., Johnson, D. H., Grindey, G. B., Jackson, L. E. and Greco, F. A., Phase I clinical study of N-[(4-chlorophenylamino)]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).Cancer Res., 49, 5217–5220 (1989).
3. Howbert, J. J., Sulofenur.Drugs Future., 16, 517–520 1991.
4. Grindey, G. B., Boder, G. B., Grossman, C. S., Howbert, J. J., Poore, G. A., Shaw, W. H., Todd, G. C. and Worzalla, J. F., Further development of diarylsulfonylureas as novel anticancer drugs.Proc. Am. Assoc. Cancer Res., 28, 309 (1987).
5. Grindey, G. B., Identification of diarysulfonylureas as novel anticancer drugs.Proc. Am. Assoc. Cancer Res., 29, 535 (1988).